Study of Quetiapine Monotherapy in Ambulatory Bipolar Spectrum Disorder With Moderate-to-Severe Hypomanic Symptoms or Mild Manic Symptoms

NCT00277667 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Bipolar Disorder

Interventions

DRUG: Quetiapine

Sponsor

Lindner Center of HOPE

Collaborators

[object Object]
[object Object]